Breaking News - The Fly

Open Search

KYMR

Kymera Therapeutics

$

()

Kymera Therapeutics announces presentation at AACR annual meeting

KYMR

4/8/2024 - 07:09am

Kymera Therapeutics presents preclinical data for STAT6, TYK2 degrader programs

KYMR

3/8/2024 - 10:07am

Kymera Therapeutics price target raised by $13 at Truist, here's why

KYMR

3/1/2024 - 09:59am

Kymera Therapeutics price target raised by $17 at Piper Sandler, here's why

KYMR

2/27/2024 - 07:24am

Kymera Therapeutics price target raised by $4 at Guggenheim, here's why

KYMR

2/23/2024 - 08:42am

Kymera Therapeutics price target raised by $15 at B. Riley, here's why

KYMR

2/23/2024 - 08:28am

Kymera Therapeutics price target raised by $4 at Wells Fargo, here's why

KYMR

2/23/2024 - 07:35am

Kymera Therapeutics price target raised by $20 at Stifel, here's why

KYMR

2/23/2024 - 07:17am

Kymera Therapeutics price target raised by $16 at H.C. Wainwright, here's why

KYMR

2/23/2024 - 06:09am

Kymera Therapeutics sees cash runway into 1H27

KYMR

2/22/2024 - 07:05am

Kymera Therapeutics reports Q4 EPS (25c), consensus (40c)

KYMR

2/22/2024 - 07:04am

Kymera Therapeutics initiated with neutral view at Wolfe Research, here's why

KYMR

2/14/2024 - 19:31pm

Kymera Therapeutics initiated with neutral view at Wolfe Research

KYMR

2/14/2024 - 16:17pm

Kymera Therapeutics provides 2024 corporate goals

KYMR

1/9/2024 - 09:20am

Kymera Therapeutics sees cash runway into 1H27

KYMR

1/9/2024 - 09:18am